From DCPD to NTCP: The long journey towards identifying a functional hepatitis B virus receptor
Jisu Li, Shuping Tong
Clin Mol Hepatol. 2015;21(3):193-199. Published online 2015 Sep 30 DOI: https://doi.org/10.3350/cmh.2015.21.3.193
|
Citations to this article as recorded by
Neuropilin-1 is a novel host factor modulating the entry of hepatitis B virus
Haibo Yu, Jihua Ren, Haijun Deng, Linfeng Li, Zhenzhen Zhang, Shengtao Cheng, Zufeng Guo, Ailong Huang, Yongjun Dang, Kunling Song, Daiqing Wu, Xinyan Yao, Yiping Qin, Zhen Yang, Kexin Xu, Xin He, Juan Chen
Journal of Hepatology.2024;[Epub] CrossRef PreS/2-21-Guided siRNA Nanoparticles Target to Inhibit Hepatitis B Virus Infection and Replication
Lixia Gao, Jie Yang, Jutao Feng, Ziying Liu, Ying Dong, Jiangyan Luo, Liangzhentian Yu, Jiamei Wang, Hongying Fan, Weifeng Ma, Tiancai Liu
Frontiers in Immunology.2022;[Epub] CrossRef Regulation of the HBV Entry Receptor NTCP and its Potential in Hepatitis B Treatment
Yan Li, Jun Zhou, Tianliang Li
Frontiers in Molecular Biosciences.2022;[Epub] CrossRef Tracing the evolutionary history of hepadnaviruses in terms of e antigen and middle envelope protein expression or processing
Qianru Wang, Yanli Qin, Jing Zhang, Lucy Jia, Shuwen Fu, Yongxiang Wang, Jisu Li, Shuping Tong
Virus Research.2020; 276: 197825. CrossRef Infección por el virus de la hepatitis delta
Melissa Montoya-Guzmán, Carolina Posada-Álvarez, Laura Camila Lopera-Restrepo, Diana di Filippo-Villa, María-Cristina Navas
Hepatología.2020; : 116. CrossRef The p.Ser267Phe variant of sodium taurocholate cotransporting polypeptide (NTCP) supports HBV infection with a low efficiency
Chenxuan Liu, Guangwei Xu, Zhenchao Gao, Zhongmin Zhou, Guilan Guo, Dan Li, Zhiyi Jing, Jianhua Sui, Wenhui Li
Virology.2018; 522: 168. CrossRef Host functions used by hepatitis B virus to complete its life cycle: Implications for developing host-targeting agents to treat chronic hepatitis B
Bidisha Mitra, Roshan J. Thapa, Haitao Guo, Timothy M. Block
Antiviral Research.2018; 158: 185. CrossRef Cyclosporin derivatives inhibit hepatitis B virus entry without interfering with NTCP transporter activity
Satomi Shimura, Koichi Watashi, Kento Fukano, Michael Peel, Ann Sluder, Fumihiro Kawai, Masashi Iwamoto, Senko Tsukuda, Junko S. Takeuchi, Takeshi Miyake, Masaya Sugiyama, Yuki Ogasawara, Sam-Yong Park, Yasuhito Tanaka, Hiroyuki Kusuhara, Masashi Mizokami
Journal of Hepatology.2017; 66(4): 685. CrossRef Inhibition of hepatitis B viral entry by nucleic acid polymers in HepaRG cells and primary human hepatocytes
Clément Guillot, Nora Martel, Françoise Berby, Isabelle Bordes, Olivier Hantz, Matthieu Blanchet, Camille Sureau, Andrew Vaillant, Isabelle Chemin, Sibnarayan Datta
PLOS ONE.2017; 12(6): e0179697. CrossRef Hepatitis delta: virological and clinical aspects
Luan Felipo Botelho-Souza, Mariana Pinheiro Alves Vasconcelos, Alcione de Oliveira dos Santos, Juan Miguel Villalobos Salcedo, Deusilene Souza Vieira
Virology Journal.2017;[Epub] CrossRef Roles of hepatocyte nuclear factors in hepatitis B virus infection
Doo Hyun Kim, Hong Seok Kang, Kyun-Hwan Kim
World Journal of Gastroenterology.2016; 22(31): 7017. CrossRef
|